M.d. Anderson Cancer Center

This early-phase trial tests a virus called DNX-2401 that is designed to infect and destroy cancer cells in people with advanced melanoma that has spread to the brain and/or other parts of the body. The main goal is to find the safest dose and number of injections. About 50 adult…

This study is testing a new procedure called nanosecond pulsed field ablation (nsPFA) to treat benign thyroid nodules. The procedure uses electrical pulses to shrink thyroid lumps without surgery. Researchers will enroll 30 adults with confirmed benign nodules larger than 2cm to …

This is an early, small study to learn how a standard cancer drug (cabozantinib) changes the immune environment inside bones where kidney cancer has spread. Researchers will take small tissue samples (biopsies) from the bone before and after treatment to see what happens. The mai…